Steven Cohen's AMRX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 78,105 shares of Amneal Pharmaceuticals, Inc. (AMRX) worth $970,845, representing 0.00% of the portfolio. First purchased in 2018-Q3, this medium-term investment has been held for 20 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in AMRX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2019, adding 3.32 M shares. Largest reduction occurred in Q4 2022, reducing 2.75 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Amneal Pharmaceuticals (AMRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Amneal Pharmaceuticals (AMRX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +78,105 | New Buy | 78,105 | $12.43 |
| Q2 2025 | -446,000 | Sold Out | 0 | $0.00 |
| Q1 2025 | +446,000 | New Buy | 446,000 | $8.38 |
| Q2 2024 | -60,500 | Sold Out | 0 | $0.00 |
| Q1 2024 | +60,500 | New Buy | 60,500 | $6.06 |
| Q4 2023 | -124,000 | Sold Out | 0 | $0.00 |
| Q3 2023 | +124,000 | New Buy | 124,000 | $4.22 |
| Q4 2022 | -2.75 M | Sold Out | 0 | $0.00 |
| Q3 2022 | -714,900 | Reduce 20.63% | 2.75 M | $2.02 |
| Q2 2022 | +466,020 | Add 15.54% | 3.46 M | $3.18 |
| Q1 2022 | -312,520 | Reduce 9.44% | 3 M | $4.17 |
| Q4 2021 | -433,600 | Reduce 11.58% | 3.31 M | $4.79 |
| Q3 2021 | +1.92 M | Add 105.23% | 3.74 M | $5.34 |
| Q2 2021 | -1.11 M | Reduce 37.76% | 1.82 M | $5.12 |
| Q1 2021 | +2.93 M | New Buy | 2.93 M | $6.73 |
| Q4 2019 | -1.01 M | Sold Out | 0 | $0.00 |
| Q3 2019 | -2.3 M | Reduce 69.48% | 1.01 M | $2.90 |
| Q2 2019 | +3.32 M | New Buy | 3.32 M | $7.17 |
| Q4 2018 | -800,000 | Sold Out | 0 | $0.00 |
| Q3 2018 | +800,000 | New Buy | 800,000 | $22.19 |
Steven Cohen's Amneal Pharmaceuticals Investment FAQs
Steven Cohen first purchased Amneal Pharmaceuticals, Inc. (AMRX) in Q3 2018, acquiring 800,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Amneal Pharmaceuticals, Inc. (AMRX) for 20 quarters since Q3 2018.
Steven Cohen's largest addition to Amneal Pharmaceuticals, Inc. (AMRX) was in Q2 2019, adding 3,315,460 shares worth $23.77 M.
According to the latest 13F filing for Q1 2026, Steven Cohen's firm, Point72 Asset Management, L.P., owns 78,105 shares of Amneal Pharmaceuticals, Inc. (AMRX), valued at approximately $970,845.
As of the Q1 2026 filing, Amneal Pharmaceuticals, Inc. (AMRX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Amneal Pharmaceuticals, Inc. (AMRX) was 3,745,000 shares, as reported at the end of Q3 2021.